Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.
about
Targeting folate receptor alpha for cancer treatmentPotent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.Targeted delivery of platinum-taxane combination therapy in ovarian cancer.Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide BiosyEpigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17Therapeutic targets and new directions for antibodies developed for ovarian cancer.Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer ModelsChemically Programmed Bispecific Antibodies in Diabody Format.Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]pyrimidine Antifolates.New Approaches for Immune Directed Treatment for Ovarian Cancer.Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research.MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles.Light induced drug release from a folic acid-drug conjugate.Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.Characterization, Cytotoxicity, and Genotoxicity of TiO2 and Folate-Coupled Chitosan Nanoparticles Loading Polyprenol-Based Nanoemulsion.A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.Advances in ovarian cancer therapy.Folate-Targeted Surface-Enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detection of Microscopic Ovarian Cancer.Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.Clinical application of a rapid cervical cancer screening method: Folate receptor-mediated staining of cervical neoplastic epithelia.Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
P2860
Q26744215-9ED68B35-9C2B-42F6-9088-C3007010FCBEQ33900573-529FBA13-F653-41B8-9A4E-21F291BE2A6AQ33914066-3FC59BA9-C715-4D8E-B5F3-C485B756C473Q36395811-AC4C5460-CAF5-432E-9DA8-C28630F8E3D8Q37246257-0E33894A-AA90-4F6E-88C1-6B40B97E2528Q37260961-006FE4A6-DBCA-4175-B7B1-0354107FA3F2Q37362630-E0B7DFA6-1515-4856-AAB1-5C545F78F6F4Q37397674-C1F9AB82-61AF-4E4E-B1C0-69CD4CD33359Q37447340-EEBBABD4-C2E9-47EF-868D-57920B130172Q38436973-E619EC78-3281-4274-811D-4E05F1F7340AQ38524502-E0076CE8-BD93-4B74-842C-A361B2E5B151Q38718741-14725361-D9B3-47F1-8E66-5E516EDAD2B8Q38760516-604E5A99-58E1-46E9-B8C2-2F210E11F6BBQ38940035-D338922F-2878-459F-8CBD-E542EC283036Q38995020-956FEAE6-5578-4431-9D56-C6B37E717EB3Q39314843-A040F111-1334-420B-A013-1AB47DCBFBA1Q42736005-BB30401F-26F8-48B0-B262-53A1B1739520Q45049944-D1E2F038-F5AC-48E1-BDB1-8EEF68A9C915Q46871150-6FA6F305-1BF9-4A85-A9C8-EFA352A6464DQ47850161-235C6714-B1D8-4602-91AA-6A58A563E0FFQ47861842-D703B7D2-4B4C-42F2-8C30-B79904C3F330Q47926770-654C521B-23D0-4CD2-B1EE-AFB9608EE0F8Q48104995-05E6A6AF-A055-4CAE-BE95-BAE96E74B37DQ48138644-0471CE71-48EC-4711-8D53-9BA275475897Q48234647-BA9F293C-BB1F-4A6A-911B-FFB539FAE35FQ50196523-7D45EF69-91E0-43B6-A84B-6B9AF8C28620Q52559376-EAE9966D-C800-44EA-9EBE-1615697A9527Q53686098-82E14FB3-5330-494D-B06F-37863E5C21E5Q55008640-9ED7B237-2804-4BB7-9759-A4841EE37CDAQ59134002-DE85DA1C-AF5F-4A37-B0B6-5A06F4C4F3F7
P2860
Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Role of the folate receptor in ...... sm, and clinical implications.
@en
type
label
Role of the folate receptor in ...... sm, and clinical implications.
@en
prefLabel
Role of the folate receptor in ...... sm, and clinical implications.
@en
P2093
P2860
P1476
Role of the folate receptor in ...... sm, and clinical implications.
@en
P2093
Christian Marth
Ignace B Vergote
Robert L Coleman
P2860
P2888
P356
10.1007/S10555-014-9539-8
P577
2015-03-01T00:00:00Z
P6179
1022427139